October 6 University
El-Sheikh Zayed City, Giza Governorate, 1133, Egypt
NCT Number: NCT05790421
Foot muscle energy technique and conventional physical therapy program administered in patients with type 2 Diabetic Neuropathy.
Looking for future studies?
Notify Me40 year–55 year
All sexes
Interventional
Not applicable
El-Sheikh Zayed City, Giza Governorate, 1133, Egypt
Foot muscle energy technique and conventional physical therapy program administered in patients with type 2 Diabetic Neuropathy.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Starting from the preparation position, at the restriction barrier, the patient is asked to exert a small effort (no more than 20% of available strength) towards plantarflexion, against unyielding resistance, with appropriate breathing. The patient produces isometric effort contracts either gastrocnemius or soleus (depending on whether the knee is unflexed or flexed). This contraction is held for 7-10 seconds together with a held breath. The exercise was repeated until the full range of movement was obtained.
Other names: Foot MET
Graduated active resisted range of motion exercises for both UL and LL and graduated gait training
Time frame: 4 weeks
Assess both tibial and deep peroneal motor nerve conduction velocity.
Time frame: 4 weeks
Assess Isometric muscle strength.
October 6 University
Other
Effect of Foot Muscle Energy Technique in Patients With Diabetic Neuropathy: A Randomized Controlled Trial
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06292962
Diabetes Complications, Diabetes Mellitus
Lahore, Pakistan
View Trial DetailsNCT06482827
Diabetes Complications, Diabetes Mellitus
Hamilton, Ontario, Canada
View Trial DetailsNCT05683106
Cardiovascular Diseases, Diabetes Complications
São Paulo, Brazil
View Trial DetailsNCT06025422
Cardiovascular Diseases, Diabetes Complications
Leicester, Leicestershire, United Kingdom
View Trial Details